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Abstract.; New tools to detect exposure of free-range Eurasian wild boar (Sus scrofa scrofa) to pathogenic
mycobacteria would be valuable for improved disease surveillance and wildlife management. Two hundred
sera from wild boar of known Mycobacterium bovis infection status were used to evaluate test suitability for
the detection of antibodies against M. bovis and Mycobacterium avium subsp. paratuberculosis (or cross-
reacting members of the M. avium complex). Two traditional enzyme-linked immunosorbent assays were
evaluated using M. bovis purified protein derivative (bPPD) and paratuberculosis protoplasmatic antigen 3
(PPA3) as antigens, respectively, and a new point-of-care test format for bovine tuberculosis (bTB) that uses
the innovative dual-path platform (DPP TB) test. The effect of individual factors (sex, age, lesions) on the
diagnostic performance of the serologic tests was also determined. Although the DPP had a sensitivity of
89.6% and a specificity of 90.4%, for bPPD, the sensitivity was 79.2% and the specificity 100%. Both tests had
a kappa agreement of 0.80. Sixty-five of 68 (95.6%) wild boar sera with antibodies against the PPA3 antigen
corresponded to known M. bovis–infected wild boar. Significant differences were not observed in the bPPD
and DPP readings among lesion categories or between age classes. A slight sex-related difference in sensitivity
toward males in the DPP was found, but it was not detected in the bPPD enzyme-linked immunosorbent
assay. The results support the use of antibody-based diagnostic tests for both large-scale and individual bTB
testing of Eurasian wild boar and suggest that wild boar cannot be used as sentinels for infections caused by
M. avium complex members.
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Introduction
The Eurasian wild boar (Sus scrofa scrofa) is the
most widespread free-ranging ungulate in large areas
of Europe. Depending on habitat and management,
wild boar numbers range from almost zero to up to 90
individuals per square km.1 The continuing expansion
of this species raises concerns regarding the control of
diseases shared with livestock.15 Due to their rooting
habits, omnivorous diet, ability to cross barriers and
contact with a broad range of wild and domestic
animals,7,16 and susceptibility to mycobacterial infec-
tions,19 wild boar or their feral pig relatives have been
used as disease sentinels.22 In southwestern Europe,
bovine tuberculosis (bTB), caused by Mycobacterium
bovis, and paratuberculosis, caused by Mycobacteri-
um avium subsp. paratuberculosis infection, are
diseases of concern in wild and domestic ruminants.24
Hence, setting up new tools to detect exposure of free-
range wild boar to pathogenic mycobacteria would be
a valuable tool for improved disease surveillance and
wildlife management.
The mycobacterial species isolated from wild boar
include M. bovis and other members of the Myco-
bacterium tuberculosis complex (MTBC); M. avium
subsp. avium, M. avium subsp. hominissuis, and M.
avium subsp. paratuberculosis of the M. avium
complex (MAC); and other potentially pathogenic
mycobacteria.19 In southwestern Europe, M. bovis is
the most frequently detected mycobacterial pathogen
in wild boar, with local prevalence as high as 52% in
certain areas.13 The abundant populations living in
Mediterranean habitats of southwestern Europe are
considered true wildlife reservoirs for M. bovis
infection.21 In contrast, members of the MAC are
only sporadically detected.2,23 Moreover, although
most M. bovis–infected wild boar develop character-
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istic gross lesions,20 infections with MAC species
often cause only minimal pathology, if any.11
Bacterial culture is the gold standard technique for
diagnosing mycobacterial infections. However, its
sensitivity depends on the number and selection of
tissues processed10 and on sample quality.9 Antemor-
tem TB testing of wild boar has been attempted by
means of serology, tuberculin skin test, and gamma
interferon assay. The skin testing requires handling
the dangerous wild boar twice and has a poor
specificity,17 whereas gamma interferon testing re-
quires fresh blood samples, an equipped laboratory
environment, and skilled personnel.11 Detection of
specific antibodies would be a useful alternative tool.
Serum samples are easy to collect, transport, and
store. Moreover, serology is faster, less expensive and
complex, and more suitable for live animals than
culture or other techniques.26 Recently, a traditional
enzyme-linked immunosorbent assay (ELISA), which
uses M. bovis purified protein derivative (bPPD) as a
coating antigen, has shown a fair sensitivity (73%)
and good specificity (96%) in detecting infected wild
boar.3 Also, a lateral-flow rapid testa has demonstrat-
ed a sensitivity of 77% and specificity of 97% for
detecting M. bovis infection in Eurasian wild boar.18
More recently, a new point-of-care test format for
bTB that uses the innovative dual-path platform
(DPP) technologya has shown enhanced specificity in
elephants and red deer.6,14 These rapid tests have
practical advantages over other diagnostic tools,
because they are easy to perform, can be undertaken
on site, and produce results typically within 20 min.18
The present study evaluated the bPPD ELISA, the
DPP TB test, and the paratuberculosis protoplasmat-
ic antigen 3 (PPA3) ELISA for the detection of MAC
using 200 sera collected from free-ranging wild boar
and determined whether individual factors (sex, age,
and the presence of bTB compatible lesions) poten-
tially affect the diagnostic performance of the
serologic tests.
Material and methods
Samples
The samples included 96 culture-confirmed, M. bovis–
infected Eurasian wild boar from several sites in southern
Spain and 104 culture-negative, lesion-negative wild boar
from sites in northern Spain with no bTB history. Sex was
known for 171 animals (83 females, 88 males). Based on
tooth eruption patterns,25 wild boar between 7 and
12 months of age were classified as yearlings (n 5 29),
those between 12 and 24 months as subadults (n 5 43), and
those older than 2 years as adults (n 5 90). The presence or
absence of bTB-compatible lesions was recorded in detail
for all but 1 of the M. bovis–infected wild boar; 94 were also
classified by the following bTB lesion scores5,20: 0 for
animals with no visible lesions (n 5 6), 1 for animals with
lesions smaller than 1 cm (n 5 55), and 2 for animals with
at least 1 lesion larger than 1 cm (n 5 33). One animal with
lesions could not be classified because data on lesion size
were not available. Data on age and sex were available for
all 96 infected wild boar. None of the wild boar was
cultured for MAP. Additionally, 12 sera from experimen-
tally M. avium subsp. avium–infected wild boar were tested
by bPPD ELISA.11
In-house ELISAs
Serum samples were tested for anti-PPD immunoglobu-
lin antibodies by means of an ELISA using bovine
tuberculin purified protein derivative (bPPD)b as antigen
and protein G horseradish peroxidasec as a conjugate
applying the previously described protocol3 with the
following modifications. Briefly, after coating the plates
for 18 hr at room temperature, wells were washed with
phosphate buffered saline (PBS) solution containing 0.05%
Tween 20 (PBST) and blocked for 1 hr at 37uC with 200 ml
of 5% skim milk in PBST. Sera were not adsorbed with
Mycobacterium phlei saline suspension but added directly
on plate (100 ml/well) at a dilution of 1:200 in PBS and
incubated for 1 hr at 37uC. Samples, blanks, and positive
and negative controls were tested in duplicate in each plate.
Protein G was added (100 ml/well) at a dilution of 2.5 mg/ml
in PBST and incubated at 37uC for 1 hr. After revealing,
the reaction was stopped with 50 ml/well of sulfuric acid
(H2SO4; 3N), and optical density (OD) was measured in a
spectrophotometer at 450 nm. Pooled anti-PPD–positive
serum was obtained from wild boar previously described as
M. bovis culture positive and negative controls from TB-
free wild boar previously described as M. bovis culture
negative from bTB-free areas.
Sample results were expressed as an ELISA percentage
(E%) that was calculated using the following formula:
[sample E% 5 (mean sample OD/2 3 mean negative
control OD) 3 100]. Cut-off values were defined as the
ratio of the mean sample OD to the sum ODs of the
negative controls. The cut-off with the best specificity was
chosen. Serum samples with E% values greater than 100
were considered positive.
An ELISA using the PPA3 was performed to detect
antibodies against MAP in the wild boar samples. The
protocol was performed following the technique as
previously described24 but without the adsorption with
M. phlei saline suspension. The PPA3 ELISA results were
expressed as an ELISA percentage (E%) of the blanks that
was calculated using the formula [sample E% 5 (mean
sample OD/2 3 mean blank ODs) 3 100] because neither
negative nor positive controls were available for wild boar.
Dual-path platform tuberculosis test
The DPP technology involves 2 nitrocellulose strips,
which are connected in a ‘‘T’’ shape inside the cassette
device,14 which allows independent delivery of the test
sample and the antibody-detecting reagent (protein A/G
hybrid conjugated to colloidal gold particles). The DPP TB
assay was performed using 5 ml of wild boar serum, 2 drops
of buffer in the sample well, and 4 drops of buffer in the
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conjugate well, and it provided a result in 20 min. The
presence and intensity of either of the 2 separate test lines
(T1, MPB83 antigen; T2, CFP10/ESAT-6 fusion protein)
were evaluated visually (presence or absence of a band of
any intensity) and by a DPP optical reader, as described
previously.14 Reactivity of CFP10/ESAT-6 and/or MPB83
above the cut-off value of 5.0 relative light units was
considered a positive result for the presence of antibody.
Reactivity below 5.0 relative light units with the 2 test
antigens was taken as an antibody-negative result.
Statistical tests
A Kruskal–Wallis nonparametrical test was used to
evaluate the effect of bTB lesion categories on the readings
of the bPPD ELISA (E%) and the DPP (relative light units)
for DPP T1 and T2. Chi-square tests were used for
comparisons between age and sex classes. Expected frequen-
cies were always greater than 5. The kappa agreement test
was used to calculate the degree of agreement of each test
with the gold standard (bacterial culture).
Results
Table 1 presents the positivity to each test of the
known M. bovis–infected samples and of the culture-
and lesion-negative wild boar. The DPP sensitivity
(positives/known infected) was 86 of 96 (89.6%), and
DPP specificity (negatives/known uninfected) was 94
of 104 (90.4%). The ELISA sensitivity was 76 of 96
(79.2%), and ELISA specificity was 104 of 104 (100%;
Table 1). Kappa agreements are also shown in
Table 1. Sixty-five of 68 (95.6%) wild boar sera with
positive levels of antibodies against the PPA3 antigen
corresponded to known M. bovis–infected wild boar.
Figure 1 shows the serum antibody responses of 96
known M. bovis–infected wild boar to each of the
studied antigens. None of the 12 sera from M. avium
subsp. avium–infected wild boar were positive in the
bPPD ELISA.
The 94 M. bovis–infected wild boar with known
lesion status included 6 individuals with no visible
lesions, 33 with lesions smaller than 1 cm, and 55 with
larger lesions. Kruskal–Wallis tests did not reveal
statistical differences in the readings of the bPPD
ELISA (E%) and the DPP (relative light units) for
DPP T1 and T2 by means according to bTB lesion
categories (chi-square 5 1.52, 2.14, 1.46, respectively;
P . 0.05 in all cases; Fig. 2).
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Table 1. Number of sera from known Mycobacterium bovis–free (culture-negative) and known M. bovis–infected (culture-positive)
Eurasian wild boar testing positive to each of the serologic tests used.*{
bPPD ELISA PPA3 ELISA DPP T1 DPP T2 DPP TOT
Culture negative 0/104 3/104 9/104 3/104 10/104
Culture positive 76/96 65/96 83/96 42/96 86/96
Kappa agreement 0.80 0.65 0.78 0.42 0.80
* All data are divided by their respective sample size. Data are presented as positive animals/analyzed animals.
{ bPPD ELISA5 bovine-purified protein derivative enzyme-linked immunosorbent assay; PPA3 ELISA 5 paratuberculosis
protoplasmatic antigen 3 ELISA; DPP T1 5 test 1 and DPP T2 5 test 2 in the dual-path platform; DPP TOT 5 both DPP tests
combined.
Figure 1. Mean Mycobacterium bovis–purified protein derivative and paratuberculosis protoplasmatic antigen 3 optical density
index (6 standard deviation; panel 1) and tests 1 and 2 of the dual-path platform (DPP T1, DDP T2, respectively) in relative light units
(6 standard deviation; panel 2), for culture-positive (black diamonds) and culture-negative (gray squares) wild boar.
Serologic tests for detecting antibodies 0
No age-related differences in sensitivity were
observed for bPPD ELISA and DPP (chi-square 5
1.36, 0.32, respectively; 2 degrees of freedom; P .
0.05 in both cases). No sex-related difference in
sensitivity was recorded in the bPPD ELISA (chi-
square 5 1.975, P . 0.05). When the more sensitive
DPP was used, sera from known infected male wild
boar had a higher sensitivity than those from known
infected female wild boar (chi-square 5 4.2; 1 degree
of freedom; P , 0 .05; Fig. 3).
Discussion
The results confirm that in wild boar, in contrast to
many other mammalian species, antibodies against
M. bovis can be detected reliably with traditional and
rapid serology tests. Both tests showed good agree-
ment with bacterial culture. Although the bPPD
ELISA was about 10% more specific than the DPP,
the DDP test was about 10% more sensitive. As
expected, sera from M. bovis–positive wild boar
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Figure 2. Mean Mycobacterium bovis–purified protein derivative enzyme-linked immunosorbent assay percentage (upper panel)
and tests 1 and 2 of the dual-path platform (DPP T1, DPP T2, respectively) in relative light units (6 standard deviation; lower panel) of
94 M. bovis–infected wild boar with known bovine tuberculosis–compatible lesion score (0, no visible lesions; 1, lesions ,1 cm; 2, lesions
.1 cm). Differences were not significant (Kruskal–Wallis test; chi-square 5 1.52, 2.14, 1.46, respectively; P . 0.05 in all cases).
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tended to react with the PPA3 antigen designed to
detect MAC antibodies, and serum antibody positiv-
ity to PPA3 in M. bovis–negative wild boar was low.
The high specificity of the bPPD ELISA was further
confirmed by the absence of positivity among 12 wild
boar that had been infected with M. avium subsp.
avium.
The ELISA is relatively inexpensive and can be
easily automated to process large numbers of
samples. In the current study, the decision was made
to use the negative sample OD as reference for
establishing the ELISA cut off,24 rather than the
positive control OD, because negative controls were
expected to be more similar between laboratories than
positive controls. Modifications in the cut-off value
fairly reduced the specificity (11%, from 100 to 89),
while a sensitivity increase was very low (5%, from 79
to 84). At the chosen cut off for bPPD ELISA,
specificity was the maximum. Given its high specific-
ity and fair sensitivity, this test is suitable for large-
scale disease surveillance and disease monitoring in
this host. It is also a potentially useful tool as a means
to monitor the effects of eventual disease control
strategies. Because mycobacterial diseases also infect
domestic pigs,12,26 diagnostic developments for wild
boar can eventually be translated into domestic pigs.
The less specific DPP test, in turn, has the advantages
of its simplicity and speed, providing a potential
point-of-care application. This, along with its higher
sensibility, makes it ideal for field use and for testing
live animals during captures or translocations. Setting
a slightly higher cut-off value for the DPP (7.5)
produced a slightly improved specificity (94%) but
lowered sensitivity to 85%.
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Figure 3. Mycobacterium bovis–purified protein derivative enzyme-linked immunosorbent assay percentage (upper panel) and
dual-path platform sensitivity (6 standard error; lower panel) of 96 culture-positive Eurasian wild boar by age and sex.
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In most species, the antibody response to M. bovis
infection is limited, and, thus, most attempts to use
antibody detection in bTB diagnosis have shown a
rather limited sensitivity.8 In swine, the existence of a
dichotomy between the humoral and cellular immune
response has been suggested.27
The sera for PPA3 antibodies were tested to
determine if wild boar could act as potential
paratuberculosis sentinels, but the results obtained
in the study could not support this possibility. First,
the responsiveness of M. bovis–negative wild boar to
this antigen was very low, suggesting no or little
exposure to MAP (or other cross-reacting mycobac-
teria) in southwestern Europe. There was almost no
indication of exposure to MAP in sera from wild boar
collected in bTB-negative sites from northern Spain,
although MAP presence in wild ruminants in these
regions has been reported repeatedly.4 Second, the
vast majority of the PPA3 ELISA reactors (95%)
were actually confirmed M. bovis–positive wild boar.
Therefore, the study findings suggest that cross-
reactions exist between mycobacteria rather than a
genuine antibody response to MAP. Alternatively, the
lack of responsiveness to PPA3 could also be a
consequence of wild boar sera not reacting well with
immunoglobulin G to MAP antigens or that the
specific ELISA protocol used was not sensitive
enough.
Regarding the individual factors affecting the
response to the serologic tests, it was found that the
differences encountered between the mean bPPD E%
and the DPP readings among known infected wild
boar with different lesion scores were not significant.
In addition, no age-related differences in sensitivity
for bPPD ELISA and DPP were observed. Finally,
slight sex-related differences existed in sensitivity
towards males in the DPP assay but not in the bPPD
ELISA. The results of the current study support the
suitability of both tests for any age or sex group and
any lesion status. The finding of a slight trend
towards a higher sensitivity in individuals with more
severe lesions is in agreement with the stronger
antibody response expected as disease progresses.8
The finding of no age-related difference in sensitivity
suggests that both tests have the same likeliness of
detecting recently exposed juvenile wild boar as
detecting exposed adults. The difference between
males and females regarding the DPP sensitivity
remains unexplained. In conclusion, the study results
presented herein support the use of antibody-
based diagnostic tests for both large-scale and
individual bTB testing of the Eurasian wild boar
and suggest that a role for wild boar as potential
sentinels for infections caused by MAC members does
not exist.
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